Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · IEX Real-Time Price · USD
34.93
-1.36 (-3.75%)
At close: Jul 2, 2024, 4:00 PM
34.92
-0.01 (-0.03%)
After-hours: Jul 2, 2024, 4:11 PM EDT
Vera Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
51
Market Cap
1.91B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 0 | - | - |
Dec 31, 2022 | 0 | - | - |
Dec 31, 2021 | 0 | - | - |
Dec 31, 2020 | 0 | - | - |
Dec 31, 2019 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AMN Healthcare Services | 3.48B |
Fortrea Holdings | 3.01B |
Amneal Pharmaceuticals | 2.50B |
Privia Health Group | 1.69B |
Astrana Health | 1.45B |
Premier | 1.34B |
Amphastar Pharmaceuticals | 676.21M |
UFP Technologies | 407.33M |
VERA News
- 21 days ago - Vera Therapeutics Appoints Christy J. Oliger to Board of Directors - GlobeNewsWire
- 25 days ago - Vera Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference - GlobeNewsWire
- 25 days ago - Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 weeks ago - Vera Therapeutics Receives U.S. FDA Breakthrough Therapy Designation for Atacicept in Immunoglobulin A Nephropathy (IgAN) - GlobeNewsWire
- 5 weeks ago - Vera Therapeutics Presents 72-week eGFR Stabilization and Rapid Hematuria Improvement in Phase 2b ORIGIN Study of Atacicept in IgAN at the 61st European Renal Association Congress - GlobeNewsWire
- 7 weeks ago - Vera Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 3 months ago - Vera Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire
- 4 months ago - Vera Therapeutics to Participate at the 44th Annual TD Cowen Health Care Conference - GlobeNewsWire